Evidence map›Paper›PMID 32291951›Full record

ArticleChembiochem : a European journal of chemical biology2020

Mapping the Binding Interface of PET Tracer Molecules and Alzheimer Disease Aβ Fibrils by Using MAS Solid-State NMR Spectroscopy.

Zheng Niu, Riddhiman Sarkar, Michaela Aichler, Hans-Jürgen Wester, Behrooz Hooshyar Yousefi, Bernd Reif

Open access · hybridAbstract read
In one paragraph

Article in Chembiochem : a European journal of chemical biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. PET imaging of alpha-synuclein: from radiotracer design through in vitro and in vivo translation.European journal of nuclear medicine and molecular imaging · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Toward Novel [Frontiers in aging neuroscience · 2022
    Article
  7. Article
  8. Solid-state NMR spectroscopy.Nature reviews. Methods primers · 2021
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Zheng NiuMunich Center for Integrated Protein Science (CIPS-M) Department Chemie, Technische Universität München, Lichtenbergstrasse 4, 85747, Garching, Germany.
Riddhiman SarkarMunich Center for Integrated Protein Science (CIPS-M) Department Chemie, Technische Universität München, Lichtenbergstrasse 4, 85747, Garching, Germany.ORCID 0000-0001-9055-7897
Michaela AichlerHelmholtz Zentrum München, Research Unit Analytical Pathology (AAP), Ingolstädter Landstrasse 1, 85764, Neuherberg, Germany.
Hans-Jürgen WesterTechnische Universität München, Department of Pharmaceutical Radiochemistry, Walther-Meißner-Strasse 3, 85748, Garching, Germany.
Behrooz Hooshyar YousefiTechnische Universität München, Department of Pharmaceutical Radiochemistry, Walther-Meißner-Strasse 3, 85748, Garching, Germany.ORCID 0000-0003-0679-4449
Bernd ReifMunich Center for Integrated Protein Science (CIPS-M) Department Chemie, Technische Universität München, Lichtenbergstrasse 4, 85747, Garching, Germany.ORCID 0000-0001-7368-7198
Center for Integrated Protein Science Munich · DEHelmholtz Zentrum München · DEPhilipps University of Marburg · DETechnical University of Munich · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Positron emission tomography (PET) tracer molecules like thioflavin T specifically recognize amyloid deposition in brain tissue by selective binding to hydrophobic or aromatic surface grooves on the β-sheet surface along the fibril axis. The molecular basis of this interaction is, however, not well understood. We have employed magic angle spinning (MAS) solid-state NMR spectroscopy to characterize Aβ-PET tracer complexes at atomic resolution. We established a titration protocol by using bovine serum albumin as a carrier to transfer hydrophobic small molecules to Aβ(1-40) fibrillar aggregates. The same Aβ(1-40) amyloid fibril sample was employed in subsequent titrations to minimize systematic errors that potentially arise from sample preparation. In the experiments, the small molecules

Indexed as

Nuclear Magnetic Resonance, BiomolecularPositron-Emission TomographyAlzheimer DiseaseAmyloidAniline CompoundsBinding SitesCarbon IsotopesFluorescent DyesMolecular StructureThiazoles2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazoleAmyloidAniline CompoundsCarbon-13Carbon IsotopesFluorescent DyesThiazolesAlzheimer's diseaseamyloid-beta fibrilsdeuterationimaging tracermagic angle spinning solid-state NMR spectroscopypositron emission tomography

Identifiers

PMID32291951
PMCPMC7496087
OpenAlexW3015843697

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.